111 related articles for article (PubMed ID: 36638810)
1. Transcription Factor ELK3 Promotes Stemness and Oxaliplatin Resistance of Glioma Cells by Regulating RNASEH2A.
Mei Y; Chen D; He S; Ye J; Luo M; Wu Q; Huang Y
Horm Metab Res; 2023 Feb; 55(2):149-155. PubMed ID: 36638810
[TBL] [Abstract][Full Text] [Related]
2. TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2.
Liu Y; Chen M; Wu B
Assay Drug Dev Technol; 2023 Jul; 21(5):202-211. PubMed ID: 37428562
[TBL] [Abstract][Full Text] [Related]
3. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
Meng L; Xing Z; Guo Z; Liu Z
Cell Death Dis; 2020 Dec; 11(12):1063. PubMed ID: 33311496
[TBL] [Abstract][Full Text] [Related]
4. Molecular and clinical features of a potential immunotherapy target ELK3 in glioma.
Xu H; Zhang L; Gao J; Wang J; Wang Y; Xiao D; Chai S
Medicine (Baltimore); 2022 Jul; 101(30):e29544. PubMed ID: 35905257
[TBL] [Abstract][Full Text] [Related]
5. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
6. LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3.
Xia XQ; Lu WL; Ye YY; Chen J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8429-8438. PubMed ID: 32894549
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
Ahmad A; Zhang W; Wu M; Tan S; Zhu T
Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
[TBL] [Abstract][Full Text] [Related]
8. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
9. C-Fos-activated circRPPH1 contributes to glioma stemness.
Xu G; Qu J; Zhang M; Wang Q
Clin Transl Oncol; 2023 May; 25(5):1277-1286. PubMed ID: 36454517
[TBL] [Abstract][Full Text] [Related]
10. Glioma angiogenesis is boosted by ELK3 activating the HIF-1[Formula: see text]/VEGF-A signaling axis.
Yueyang M; Yaqin H; Guolian X; Wenjian Z; Yang J; Chen L; Haiyan C; Min C; Jianping D; Penggao D; Hongli Z; Liang W
BMC Cancer; 2023 Jul; 23(1):662. PubMed ID: 37452291
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinase UCHL5 stabilizes ELK3 to potentiate cancer stemness and tumor progression in pancreatic adenocarcinoma (PAAD).
Yang Y; Cao L; Guo Z; Gu H; Zhang K; Qiu Z
Exp Cell Res; 2022 Dec; 421(2):113402. PubMed ID: 36328194
[TBL] [Abstract][Full Text] [Related]
12. ELK3 Expression Correlates With Cell Migration, Invasion, and Membrane Type 1-Matrix Metalloproteinase Expression in MDA-MB-231 Breast Cancer Cells.
Heo SH; Lee JY; Yang KM; Park KS
Gene Expr; 2015; 16(4):197-203. PubMed ID: 26637400
[TBL] [Abstract][Full Text] [Related]
13. ELK3-ID4 axis governs the metastatic features of triple negative breast cancer.
Choi JH; Park JD; Choi SH; Ko ES; Jang HJ; Park KS
Oncol Res; 2023; 32(1):127-138. PubMed ID: 38188675
[TBL] [Abstract][Full Text] [Related]
14. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
[TBL] [Abstract][Full Text] [Related]
15. MiR-433-3p restrains the proliferation, migration and invasion of glioma cells via targeting SMC4.
You A; Rao G; Wang J; Li J; Zhang Y; Gu J; Ge X; Zhang K; Gao X; Wu X; Cheng L; Zhu M; Wang D
Brain Res; 2021 Sep; 1767():147563. PubMed ID: 34147470
[TBL] [Abstract][Full Text] [Related]
16. ELK3 suppresses angiogenesis by inhibiting the transcriptional activity of ETS-1 on MT1-MMP.
Heo SH; Cho JY
Int J Biol Sci; 2014; 10(4):438-47. PubMed ID: 24719561
[TBL] [Abstract][Full Text] [Related]
17. ELK3 Targeting AEG1 Promotes Migration and Invasion of Ovarian Cancer Cells under Hypoxia.
Yu X; Du C; Cui Y; Jiang Y; Feng D
Biol Pharm Bull; 2023; 46(7):883-892. PubMed ID: 37394639
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA LINC00525 Promotes the Stemness and Chemoresistance of Colorectal Cancer by Targeting miR-507/ELK3 Axis.
Wang S; Li J; Yang X
Int J Stem Cells; 2019 Jul; 12(2):347-359. PubMed ID: 31242722
[TBL] [Abstract][Full Text] [Related]
19. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis.
Li W; Ma Q; Liu Q; Yan P; Wang X; Jia X
J Mol Neurosci; 2021 Jun; 71(6):1234-1244. PubMed ID: 33188501
[TBL] [Abstract][Full Text] [Related]
20. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
